We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGNX
5651
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$28K ﹤0.01%
6,700
-5,200
-44% -$26.5K
TIVO
5652
CALL
DELISTED
Tivo Inc
TIVO
$28K ﹤0.01%
3,000
ORBK
5653
PUT
DELISTED
Orbotech Ltd
ORBK
$28K ﹤0.01%
+500
New +$27.9K
CVON
5654
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
$28K ﹤0.01%
2,300
-7,640
-77% -$84.2K
AKBA icon
5655
PUT
Akebia Therapeutics
AKBA
$234M
$27K ﹤0.01%
+4,811
New +$37.6K
ALLO icon
5656
Allogene Therapeutics
ALLO
$725M
$27K ﹤0.01%
+984
New +$26.1K
CORN icon
5657
CALL
Teucrium Corn Fund
CORN
$165M
$27K ﹤0.01%
+1,700
New +$27.6K
KNX icon
5658
CALL
Knight Transportation
KNX
$11.2B
$27K ﹤0.01%
1,092
-300
-22% -$9.29K
LEE icon
5659
Lee Enterprises
LEE
$181M
$27K ﹤0.01%
+1,264
New +$31.3K
NHTC icon
5660
Natural Health Trends
NHTC
$15M
$27K ﹤0.01%
1,453
-2,696
-65% -$59.3K
NVCR icon
5661
NovoCure
NVCR
$2.02B
$27K ﹤0.01%
805
-28,090
-97% -$1.03M
OLLI icon
5662
PUT
Ollie's Bargain Outlet
OLLI
$4.8B
$27K ﹤0.01%
+400
New +$33.3K
TOUR
5663
Tuniu
TOUR
$55.4M
$27K ﹤0.01%
551
+424
+334% +$25.7K
FOE
5664
DELISTED
Ferro Corporation
FOE
$27K ﹤0.01%
1,699
-32,581
-95% -$594K
XONE
5665
CALL
DELISTED
The ExOne Company
XONE
$27K ﹤0.01%
4,100
+300
+8% +$2.42K
CFR icon
5666
PUT
Cullen/Frost Bankers
CFR
$10.3B
$26K ﹤0.01%
300
-2,200
-88% -$214K
CTMX icon
5667
CytomX Therapeutics
CTMX
$750M
$26K ﹤0.01%
1,700
-15,622
-90% -$232K
HRL icon
5668
CALL
Hormel Foods
HRL
$13.6B
$26K ﹤0.01%
600
-4,400
-88% -$190K
MKSI icon
5669
PUT
MKS Inc
MKSI
$19.8B
$26K ﹤0.01%
400
-5,200
-93% -$376K
NSPR icon
5670
InspireMD
NSPR
$37.5M
$26K ﹤0.01%
+217
New +$34.5K
RARE icon
5671
PUT
Ultragenyx Pharmaceutical
RARE
$2.64B
$26K ﹤0.01%
+600
New +$32.8K
TBBK icon
5672
The Bancorp
TBBK
$2.81B
$26K ﹤0.01%
3,228
-18,696
-85% -$175K
USAC icon
5673
CALL
USA Compression Partners
USAC
$3.77B
$26K ﹤0.01%
+2,000
New +$29.7K
VCEL icon
5674
Vericel Corp
VCEL
$2.25B
$26K ﹤0.01%
1,469
-16,586
-92% -$248K
XPP icon
5675
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$9.09M
$26K ﹤0.01%
450

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.